Bassler Bonnie L insider trades
Bassler Bonnie L has filed 58 Form 4s with the SEC that we hold, for Royalty Pharma plc (RPRX) (Director), Regeneron Pharmaceuticals, INC. (REGN) (Director), CDTX (Director) and KLDO (Director). Across all of them we count 0 purchases worth $0 and 23 sales worth $19.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($1.8M). The largest single trade was a sale of 2,559 shares of Regeneron Pharmaceuticals, INC. worth $1.5M, dated 2021-08-05. The first filing on our record is dated 2021-07-01 and the latest 2026-09-30.
Royalty Pharma plc (RPRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Regeneron Pharmaceuticals, INC. (REGN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-01 | S, sale reported on Form 4 | 2,558 | $1.5M | 2021-07-02 |
| 2021-08-05 | S, sale reported on Form 4 | 2,559 | $1.5M | 2021-08-06 |
| 2021-08-16 | S, sale reported on Form 4 | 1,219 | $768.0K | 2021-08-17 |
| 2022-03-30 | S, sale reported on Form 4 | 1,240 | $868.0K | 2022-04-01 |
| 2022-04-07 | S, sale reported on Form 4 | 1,240 | $899.0K | 2022-04-11 |
| 2022-09-08 | S, sale reported on Form 4 | 1,279 | $878.7K | 2022-09-12 |
| 2022-09-08 | S, sale reported on Form 4 | 1,279 | $901.7K | 2022-09-12 |
| 2022-09-09 | S, sale reported on Form 4 | 609 | $451.3K | 2022-09-12 |
| 2022-12-08 | S, sale reported on Form 4 | 218 | $169.8K | 2022-12-12 |
| 2023-02-03 | S, sale reported on Form 4 | 1,021 | $795.4K | 2023-02-07 |
| 2023-03-24 | S, sale reported on Form 4 | 1,240 | $1.0M | 2023-03-27 |
| 2023-08-10 | S, sale reported on Form 4 | 853 | $673.0K | 2023-08-11 |
| 2023-08-21 | S, sale reported on Form 4 | 853 | $707.1K | 2023-08-23 |
| 2023-12-13 | S, sale reported on Form 4 | 610 | $530.7K | 2023-12-14 |
| 2024-01-03 | S, sale reported on Form 4 | 826 | $755.0K | 2024-01-04 |
| 2024-01-30 | S, sale reported on Form 4 | 827 | $793.1K | 2024-01-31 |
| 2024-02-26 | S, sale reported on Form 4 | 854 | $836.3K | 2024-02-26 |
| 2024-06-05 | S, sale reported on Form 4 | 827 | $836.1K | 2024-06-07 |
| 2024-06-24 | S, sale reported on Form 4 | 756 | $802.9K | 2024-06-25 |
| 2024-08-02 | S, sale reported on Form 4 | 756 | $842.9K | 2024-08-05 |
| 2024-08-15 | S, sale reported on Form 4 | 756 | $884.5K | 2024-08-19 |
| 2025-11-20 | S, sale reported on Form 4 | 760 | $570.0K | 2025-11-24 |
| 2026-01-07 | S, sale reported on Form 4 | 1,500 | $1.2M | 2026-01-08 |
CDTX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
KLDO
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1683607) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms